<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//adalta-elementor.cclayers.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/customized-half-life/</loc>
		<lastmod>2016-04-15T02:24:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/multi-formatting/</loc>
		<lastmod>2016-04-15T02:26:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/lungs/</loc>
		<lastmod>2016-04-15T02:28:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/eye/</loc>
		<lastmod>2016-04-15T02:35:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/topical/</loc>
		<lastmod>2016-04-15T02:35:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/pipeline/fibrosis/heart/</loc>
		<lastmod>2016-04-15T02:42:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/pipeline/fibrosis/kidney/</loc>
		<lastmod>2016-04-15T02:42:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/pipeline/fibrosis/liver/</loc>
		<lastmod>2016-04-15T02:42:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/pipeline/fibrosis/skin/</loc>
		<lastmod>2016-04-15T02:42:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/about-us/board/ian-hobson/</loc>
		<lastmod>2016-04-18T01:15:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/investor-information/investor-factsheet/adalta-fact-sheet-april-2016-2/</loc>
		<lastmod>2016-04-21T05:13:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/pipeline/adalta-pipeline/jbc-2016/</loc>
		<lastmod>2016-04-21T23:58:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/customized-half-life-2/</loc>
		<lastmod>2016-04-22T00:19:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/multi-formatting-2/</loc>
		<lastmod>2016-04-22T00:20:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/overcoming-challenging-targets-2/</loc>
		<lastmod>2016-04-22T00:20:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/investors/corporate-governance/asx-corporate-governance-principles-and-recommendations/</loc>
		<lastmod>2016-04-26T02:05:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/investors/corporate-governance/adalta-corporate-governance-statement-may2016/</loc>
		<lastmod>2016-05-11T04:13:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/biotech-daily-adalta-ipo-raise-10m-ad-114-fibrosis/bdbiotechdailyjuly2016adalta/</loc>
		<lastmod>2016-07-19T03:36:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/drug-discovery-company-adalta-raises-au10m-subscribed-australian-ipo-accelerate-new-therapies-lung-fibrosis/adalta-investor-presentation-22-august-2016-3/</loc>
		<lastmod>2016-08-22T12:06:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/test-post/admission-to-official-list/</loc>
		<lastmod>2016-08-24T08:48:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/test-post-2/market-notice-admission-and-commencement-of-quotation/</loc>
		<lastmod>2016-08-24T08:49:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/appendix-1a/appendix-1a/</loc>
		<lastmod>2016-08-24T08:50:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/information-form-checklist/information-form-and-checklist/</loc>
		<lastmod>2016-08-24T08:54:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/prospectus-dated-8-july-2016/prospectus-dated-8-july-2016/</loc>
		<lastmod>2016-08-24T08:56:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/top-twenty/top-twenty/</loc>
		<lastmod>2016-08-24T08:57:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/distribution-schedule/distribution-schedule/</loc>
		<lastmod>2016-08-24T08:58:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/constitution-adalta/constitution-adalta/</loc>
		<lastmod>2016-08-24T08:59:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/employee-share-option-plan/employee-share-option-plan/</loc>
		<lastmod>2016-08-24T09:00:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/corporate-governance-policies-committee-charters/corporate-governance-policies-and-committee-charters/</loc>
		<lastmod>2016-08-24T09:01:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/financial-accounts-30-june-2013/financial-accounts-to-30-june-2013/</loc>
		<lastmod>2016-08-24T09:02:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/financial-accounts-30-june-2014/financial-accounts-to-30-june-2014/</loc>
		<lastmod>2016-08-24T09:10:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/financial-accounts-30-june-2015/financial-accounts-to-30-june-2015/</loc>
		<lastmod>2016-08-24T09:11:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/financial-accounts-29-february-2016/financial-accounts-to-29-february-2016/</loc>
		<lastmod>2016-08-24T09:11:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/initial-directors-interest-notice/initial-directors-interest-notice/</loc>
		<lastmod>2016-08-24T09:12:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/initial-directors-interest-notice-2/initial-directors-interest-notice-2/</loc>
		<lastmod>2016-08-24T09:13:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/initial-directors-interest-notice-3/initial-directors-interest-notice-3/</loc>
		<lastmod>2016-08-24T09:14:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/initial-directors-interest-notice-4/initial-directors-interest-notice-4/</loc>
		<lastmod>2016-08-24T09:15:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/initial-directors-interest-notice-5/initial-directors-interest-notice-5/</loc>
		<lastmod>2016-08-24T09:15:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-ipo-accelerate-new-therapy-lung-fibrosis/adalta-ipo-to-accelerate-new-therapy-for-lung-fibrosis/</loc>
		<lastmod>2016-08-24T09:16:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/investor-presentation/investor-presentation/</loc>
		<lastmod>2016-08-24T09:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/becoming-substantial-holder/becoming-a-substantial-holder/</loc>
		<lastmod>2016-08-24T09:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/becoming-substantial-holder-2/becoming-a-substantial-holder-2/</loc>
		<lastmod>2016-08-24T09:31:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/becoming-substantial-holder-3/becoming-a-substantial-holder-3/</loc>
		<lastmod>2016-08-24T09:31:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/becoming-substantial-holder-4/becoming-a-substantial-holder-4/</loc>
		<lastmod>2016-08-24T09:34:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/receipt-rd-tax-incentive/receipt-of-rd-tax-incentive/</loc>
		<lastmod>2016-08-30T01:41:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/preliminary-final-report/preliminary-final-report/</loc>
		<lastmod>2016-08-30T22:16:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/receipt-innovation-connections-grant/receipt-of-innovation-connections-grant/</loc>
		<lastmod>2016-08-30T22:22:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/boishares-edition-662-26-august-2016/bioshares662/</loc>
		<lastmod>2016-08-31T01:08:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/boishares-edition-662-26-august-2016/bioshares662rbp1ad/</loc>
		<lastmod>2016-08-31T06:45:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/investors/presentations/adalta-investor-presentation-september-2016-biotech-meets-broker/</loc>
		<lastmod>2016-09-08T00:34:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/agreement-fujifilm-diosynth-biotechnologies/agreement-with-fujifilm-diosynth-biotechnologies/</loc>
		<lastmod>2016-09-11T22:54:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/ndf-research-report/2016_09_13_adalta_report_from_ndf_research/</loc>
		<lastmod>2016-09-13T22:28:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/ndf-research-report/2016_09_13_adalta_report_from_ndf_research-2/</loc>
		<lastmod>2016-09-13T22:35:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/ndf-research-issues-research-adalta/ndf-research-issues-research-on-adalta/</loc>
		<lastmod>2016-09-13T22:35:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/patersons-september-2016/1ad-note-150916/</loc>
		<lastmod>2016-09-14T22:57:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/investors/presentations/dot-2016_foley-ocular-final/</loc>
		<lastmod>2016-09-15T23:00:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/investors/presentations/dot-2016_foley-final/</loc>
		<lastmod>2016-09-15T23:00:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/drug-therapy-conferences-presentations/adalta-discovery-on-target-september-2016-final/</loc>
		<lastmod>2016-09-16T00:33:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/drug-therapy-conferences-presentations/adalta-discovery-on-target-september-2016-final-2/</loc>
		<lastmod>2016-09-16T00:35:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/appendix-4g-corporate-governance-statement/appendix-4g-and-corporate-governance-statement/</loc>
		<lastmod>2016-09-19T04:44:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/?attachment_id=1278</loc>
		<lastmod>2016-09-19T05:22:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/change-directors-interest-notice/change-of-directors-interest-notice/</loc>
		<lastmod>2016-09-21T07:50:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/appendix-3b/appendix-3b-27-september-2016/</loc>
		<lastmod>2016-09-26T23:14:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/appendix-3b/appendix-3b-27-september-2016-updated/</loc>
		<lastmod>2016-09-27T01:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/change-directors-interest-notice-2/change-of-directors-interest-notice-sc/</loc>
		<lastmod>2016-09-27T01:32:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/change-directors-interest-notice-3/change-of-directors-interest-notice-pm/</loc>
		<lastmod>2016-09-27T01:32:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/notice-annual-general-meeting-2016/adalta-nom-agm-2016-final-signed/</loc>
		<lastmod>2016-10-03T23:51:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/notice-annual-general-meeting-2016/adalta-nom-agm-2016-final-signed-2/</loc>
		<lastmod>2016-10-06T09:10:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/update-orphan-drug-designation/adalta-orphan-drug-application-14-october-2016-final/</loc>
		<lastmod>2016-10-13T20:54:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/investors/presentations/adalta-investor-presentation-october-2016/</loc>
		<lastmod>2016-10-17T21:22:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-present-forthcoming-industry-conferences/adalta-conference-release-final/</loc>
		<lastmod>2016-10-18T01:58:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-present-forthcoming-industry-conferences/adalta-conference-release-final-2/</loc>
		<lastmod>2016-10-19T03:07:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/appendix-3b-2/appendix-3b-2/</loc>
		<lastmod>2016-10-23T05:23:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/change-directors-interest-notice-4/change-of-directors-interest-notice-jc/</loc>
		<lastmod>2016-10-23T05:25:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/quarterly-review-appendix-4c/adalta-4c/</loc>
		<lastmod>2016-10-26T21:53:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/collaboration-agreement-xl-protein/collaboration-agreement-with-xl-protein/</loc>
		<lastmod>2016-11-07T08:18:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/commercialisation-agreement-crossbeta-biosciences/collaboration-agreement-with-xl-protein-2/</loc>
		<lastmod>2016-11-08T05:50:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/commercialisation-agreement-crossbeta-biosciences/commercialisation-agreement-with-crossbeta-biosciences/</loc>
		<lastmod>2016-11-08T05:51:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/agm-presentation/adalta-agm-presentation-2016/</loc>
		<lastmod>2016-11-14T02:34:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/results-of-agm/results-of-agm-2016/</loc>
		<lastmod>2016-11-14T05:40:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/new-director/robert-peach-ned-adalta/</loc>
		<lastmod>2016-11-14T22:00:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/initial-directors-interest-notice-6/directors-interest-notice-rp/</loc>
		<lastmod>2016-11-14T22:59:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/about-us/board/robert-peach/</loc>
		<lastmod>2016-11-17T00:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/about-us/board/robert-peach-2/</loc>
		<lastmod>2016-11-17T06:49:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/ndf-research-issues-research-adalta/2016-09-13-adalta-ltd-report-from-ndf-research/</loc>
		<lastmod>2016-12-04T23:14:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/about-us/board/robert-peach-1/</loc>
		<lastmod>2016-12-15T03:40:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/about-us/management/man-1/</loc>
		<lastmod>2016-12-15T03:42:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/?attachment_id=1389</loc>
		<lastmod>2016-12-21T01:56:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/?attachment_id=1390</loc>
		<lastmod>2016-12-21T01:56:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/?attachment_id=1391</loc>
		<lastmod>2016-12-21T01:58:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/positive-pre-clinical-data/new-pre-clinical-data-january-2017/</loc>
		<lastmod>2017-01-08T22:18:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/investors/presentations/adalta-biotech-showcase-presentation-january-2017/</loc>
		<lastmod>2017-01-08T22:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-receives-orphan-designation-ad-114/adalta-odd-jan-2017/</loc>
		<lastmod>2017-01-18T00:34:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/positive-results-adalta-bioshares-edition-680-january-2017/bioshares680rbp1ad/</loc>
		<lastmod>2017-01-24T01:51:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-appendix-4c-quarterly/adalta-appendix-4c-dec-2016-31-01-2017/</loc>
		<lastmod>2017-01-30T22:14:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/release-securities-escrow/escrow/</loc>
		<lastmod>2017-02-01T01:35:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/half-yearly-report-accounts/half-yearly-report-and-accounts/</loc>
		<lastmod>2017-02-14T07:01:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/bodies-continue-make-progress-ndf-research-february-2017/2017_02_20_adalta_ltd_update_report_from_ndf_research_v1/</loc>
		<lastmod>2017-02-20T01:15:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/fibrosis-symposium-presentation-material/adalta-investor-day-21-feb-2017/</loc>
		<lastmod>2017-02-22T22:35:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/appendix-3b-3/attachment/1647455/</loc>
		<lastmod>2017-02-22T22:40:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/investors/presentations/adalta-investor-day-21-feb-2017-presentations/</loc>
		<lastmod>2017-02-22T22:51:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-expands-partnership-alfred-hospital/attachment/1657008/</loc>
		<lastmod>2017-03-20T21:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/bioshares-edition-688-march-2017/bioshares688/</loc>
		<lastmod>2017-03-20T21:58:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/bioshares-edition-688-march-2017/bioshares688rbp1ad/</loc>
		<lastmod>2017-03-21T00:41:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/ticking-right-boxes-way-clinical-trials-patersons-march-2017/1ad-note-310317/</loc>
		<lastmod>2017-03-31T00:35:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/scientific-advisors/stevefelstead/</loc>
		<lastmod>2017-04-27T05:30:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/about-us/board/cameron-jones/</loc>
		<lastmod>2017-06-22T01:54:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/i-body-graphic/</loc>
		<lastmod>2017-07-11T05:07:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/pipeline/fibrosis/ipfinfo/</loc>
		<lastmod>2017-07-11T05:55:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/i-body-graphic-2/</loc>
		<lastmod>2017-07-11T06:00:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/home-2/adalta-corporate-fact-sheet-aug2017/</loc>
		<lastmod>2017-08-04T06:13:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/ipf-profile-glen-westall/dsc05182/</loc>
		<lastmod>2017-08-31T05:18:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/pulmonary-fibrosis-awareness-month-2017/img_8978-copy/</loc>
		<lastmod>2017-09-05T23:14:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/pulmonary-fibrosis-awareness-month-2017/stan-1/</loc>
		<lastmod>2017-09-05T23:14:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/investors/corporate-governance/corporate-governance-statement-2017/</loc>
		<lastmod>2017-09-06T09:24:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/investors/corporate-governance/adalta-board-skills-matrix-sep-17/</loc>
		<lastmod>2017-09-06T09:40:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/pulmonary-fibrosis-awareness-month-2017/_mg_8825a-anne-holland_physiotherapist/</loc>
		<lastmod>2017-09-13T23:04:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/pulmonary-fibrosis-awareness-month-2017/max-1-3/</loc>
		<lastmod>2017-09-18T06:18:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/pulmonary-fibrosis-awareness-month-2017/bill-2/</loc>
		<lastmod>2017-09-25T02:34:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/about-us/management/dallas-headshot/</loc>
		<lastmod>2017-10-09T03:19:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-gets-commercial-ready-pre-clinical-safety-studies-show-promising-results/photograph-by-arsineh-houspian-61-401320173-arsineharsineh-com/</loc>
		<lastmod>2017-11-22T02:29:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-gets-commercial-ready-pre-clinical-safety-studies-show-promising-results/photograph-by-arsineh-houspian-61-401320173-arsineharsineh-com-2/</loc>
		<lastmod>2017-11-22T02:30:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/home-2/adalta-corporate-newsletter-december-2017/</loc>
		<lastmod>2017-12-20T01:16:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/morgans-interview-sam-cobb/photograph-by-arsineh-houspian-61-401320173-arsineharsineh-com-3/</loc>
		<lastmod>2018-01-02T04:27:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/researcher-looks-next-generation-antibody-treatment-chronic-kidney-disease/normal-kidney-biopsy/</loc>
		<lastmod>2018-01-15T23:36:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/researcher-looks-next-generation-antibody-treatment-chronic-kidney-disease/diabetic-nephropathy-kidney-biopsy/</loc>
		<lastmod>2018-01-15T23:36:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/researcher-looks-next-generation-antibody-treatment-chronic-kidney-disease/carol-pollock/</loc>
		<lastmod>2018-01-15T23:37:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/researcher-looks-next-generation-antibody-treatment-chronic-kidney-disease/carol-pollock-2/</loc>
		<lastmod>2018-01-15T23:37:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/?attachment_id=268</loc>
		<lastmod>2018-02-07T03:50:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/?attachment_id=2020</loc>
		<lastmod>2018-02-07T03:54:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/the-i-body-platform/gpcr/</loc>
		<lastmod>2018-02-13T01:14:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/?attachment_id=2069</loc>
		<lastmod>2018-02-13T05:00:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/?attachment_id=2070</loc>
		<lastmod>2018-02-13T05:02:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/?attachment_id=2074</loc>
		<lastmod>2018-02-13T05:27:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/i-bodies/molecule-size/</loc>
		<lastmod>2018-02-13T05:51:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/the-i-body-platform/ion-channel-2-2/</loc>
		<lastmod>2018-02-13T23:36:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/the-i-body-platform/the-market-for-drugs-that-target-gpcrs/</loc>
		<lastmod>2018-02-14T00:11:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/the-i-body-platform/the-i-body-a-unique-binder-to-drug-targets/</loc>
		<lastmod>2018-02-14T00:11:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/the-i-body-platform/screening-the-i-body-library/</loc>
		<lastmod>2018-02-14T00:11:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/i-bodies/generation-of-the-i-body/</loc>
		<lastmod>2018-02-14T00:51:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/scientific-advisors/hs-hausi/</loc>
		<lastmod>2018-03-28T23:18:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-advance-improved-lung-fibrosis-therapy-ad-214/ad-114-to-ad-214-image/</loc>
		<lastmod>2018-04-17T05:45:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/i-bodies/the-i-body-a-unique-binder-to-drug-targets2/</loc>
		<lastmod>2018-04-17T22:07:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/i-bodies/half-life-technologies/</loc>
		<lastmod>2018-04-17T22:09:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/technology/i-bodies/half-life-technologies-2/</loc>
		<lastmod>2018-04-17T22:12:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/pipeline/adalta-pipeline/slide3/</loc>
		<lastmod>2018-05-01T00:02:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/pipeline/adalta-pipeline/ad-114-to-ad-214-image-2/</loc>
		<lastmod>2018-05-01T00:05:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-seeking-head-drug-discovery/new-slider2/</loc>
		<lastmod>2018-05-22T06:43:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/home-2/adalta-corporate-fact-june-2018-final/</loc>
		<lastmod>2018-06-04T23:33:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/home-2/adalta-june-2018-shareholder-update-final/</loc>
		<lastmod>2018-06-04T23:34:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adaltas-lead-program-ad-214-profiled-clinical-leader/slider2b/</loc>
		<lastmod>2018-06-27T07:14:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/smaller-smarter-antibody-like-drugs-update-report-ndf-research/ndf-10-reasons/</loc>
		<lastmod>2018-07-05T06:33:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/smaller-smarter-antibody-like-drugs-update-report-ndf-research/ndf-10-reasons-2/</loc>
		<lastmod>2018-07-05T06:34:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/smaller-smarter-antibody-like-drugs-update-report-ndf-research/ndf-10-reasons-3/</loc>
		<lastmod>2018-07-05T23:05:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-present-biotech-showcase-san-francisco/photograph-by-arsineh-houspian-61-401320173-arsineharsineh-com-4/</loc>
		<lastmod>2018-07-10T00:13:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/top-female-biotech-ceo-committed-readdressing-gender-imbalance-life-sciences/image002/</loc>
		<lastmod>2018-07-16T06:40:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/top-female-biotech-ceo-committed-readdressing-gender-imbalance-life-sciences/image003/</loc>
		<lastmod>2018-07-16T06:40:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/top-female-biotech-ceo-committed-readdressing-gender-imbalance-life-sciences/image004/</loc>
		<lastmod>2018-07-16T06:40:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/ceo-sam-cobb-profiled-fairfax-media-watch-csl-come/photograph-by-arsineh-houspian-61-401320173-arsineharsineh-com-5/</loc>
		<lastmod>2018-07-16T06:40:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adaltas-body-platform-reaching-high-hanging-fruit/low-hanging-fruit/</loc>
		<lastmod>2018-07-24T07:00:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/pulmonary-fibrosis-awareness-month-2018/screen-shot-2018-09-05-at-10-12-41-am/</loc>
		<lastmod>2018-09-05T01:22:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/pulmonary-fibrosis-awareness-month-2018/lkfl_getting-ready/</loc>
		<lastmod>2018-09-05T01:42:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/pulmonary-fibrosis-awareness-month-2018/img_4407/</loc>
		<lastmod>2018-09-05T01:49:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/pulmonary-fibrosis-awareness-month-2018/screen-shot-2018-09-05-at-2-02-33-pm/</loc>
		<lastmod>2018-09-05T04:30:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-named-finalist-australian-technologies-competition/atc-finalist/</loc>
		<lastmod>2018-09-18T00:02:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/shareholder-update-december-2018/adalta-corporate-newsletter-december-2018-4pp-v3/</loc>
		<lastmod>2018-12-03T00:44:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/idiopathic-pulmonary-fibrosis-adaltas-body-approach/adalta-ipf-white-paper-jan-2019-final/</loc>
		<lastmod>2019-01-31T04:54:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/rollercoaster-ride-biotech-ceo-sam-cobb-profiled-us-life-science-leader/photograph-by-arsineh-houspian-61-401320173-arsineharsineh-com-6/</loc>
		<lastmod>2019-04-03T02:42:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/investors-2/prospectus-adalta-23-05-19/</loc>
		<lastmod>2019-05-22T23:44:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/shareholder-update-june-2019/adalta-corporate-newsletter-june-2019-4pp-final/</loc>
		<lastmod>2019-06-10T22:53:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/flexible-formatting-adaltas-body-technology/i-body-half-life-variants/</loc>
		<lastmod>2019-06-24T05:16:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/ausbiotech-case-study-scarred-life/ausbiotech-fibrosis-case-study-june-2019/</loc>
		<lastmod>2019-06-24T23:29:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/flurry-deals-demonstrates-significant-pharma-interest-ipf/pharma-licensing/</loc>
		<lastmod>2019-07-22T06:54:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/about-us/board/ros-wilson-web/</loc>
		<lastmod>2019-07-31T22:58:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/about-us/board/tim_o_web/</loc>
		<lastmod>2019-10-16T05:30:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/home-2/investorpresentationforaustralianmicrocapconference_compressed/</loc>
		<lastmod>2019-10-21T22:04:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/investor-information/investor-factsheet/adalta-corporate-fact-sheet-jan-2020-v6/</loc>
		<lastmod>2020-01-14T00:32:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/pathway-clinic-special-investor-analyst-briefing-2019/mick-foley-1/</loc>
		<lastmod>2020-03-13T03:39:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/article-cso-mick-foley-next-generation-antibody-like-therapeutics-published-ebr/mabs-cover/</loc>
		<lastmod>2020-04-01T22:53:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/article-cso-mick-foley-next-generation-antibody-like-therapeutics-published-ebr/antibodies-and-beyond/</loc>
		<lastmod>2020-04-05T23:45:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/about-us/management/claudiagkweb/</loc>
		<lastmod>2020-04-09T07:05:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/about-us/management/claudiagkweb-2/</loc>
		<lastmod>2020-04-09T07:10:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/ceo-dr-tim-oldham-interviewed-pitt-street-research/pitt-street-video-pics-v2-002/</loc>
		<lastmod>2020-05-08T04:29:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-present-29-july-ird-invest/adalta-banner/</loc>
		<lastmod>2020-07-22T02:10:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/about-us/board/david-fuller_web/</loc>
		<lastmod>2020-07-24T09:28:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/looking-back-pulmonary-fibrosis-awareness-month-2020/download/</loc>
		<lastmod>2020-09-29T00:53:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-seeking-head-drug-discovery/slider-2/</loc>
		<lastmod>2022-02-20T23:20:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/about-us/management/angus/</loc>
		<lastmod>2022-09-07T05:08:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/about-us/management/angus-thumb/</loc>
		<lastmod>2022-09-07T05:10:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/about-us/management/patrick-thumb/</loc>
		<lastmod>2022-09-07T05:37:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/preferences-update-2/adalta-header/</loc>
		<lastmod>2022-10-04T23:27:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/preferences-update-2/adalta-preferences-2/</loc>
		<lastmod>2022-10-05T23:08:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/preferences-update/pref-banner/</loc>
		<lastmod>2022-12-09T00:53:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/preferences-update/pref-banner-1/</loc>
		<lastmod>2022-12-09T01:28:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/bioshares-adalta-prioritises-iv-formulation-for-ad-214/delivery/</loc>
		<lastmod>2022-12-21T03:45:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-rights-offer-webinar-recording-wednesday-3-may-2023/feature-dr-tim-oldham/</loc>
		<lastmod>2023-05-04T07:02:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-presents-at-twilight-investor-briefing/twilight-briefing-pic-1/</loc>
		<lastmod>2023-05-26T22:30:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-presents-at-investor-summit/screenshot-investor-summit-1-june-2023/</loc>
		<lastmod>2023-06-14T06:25:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-presents-at-tcn-emerging-asx-gems-conference/adalta-emerging-asx-gems-webinar-11-nov-22/</loc>
		<lastmod>2023-07-13T02:11:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-participates-in-us-emerging-growth-conference-13-july-2023/emerging-growth-conference-web-image/</loc>
		<lastmod>2023-07-14T06:54:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-talks-to-bulls-n-bears-on-developments-for-fibrosis-sufferers/tim-in-lab-with-minister/</loc>
		<lastmod>2023-07-19T02:24:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-investor-briefing-progress-of-ad-214-phase-i-extension-study/adalta-webinar-thumbnail-10-aug-2023/</loc>
		<lastmod>2023-08-14T12:40:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/adalta-education-series-issue-two-september-is-pulmonary-fibrosis-awareness-month/green-tick/</loc>
		<lastmod>2023-08-28T06:20:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/home-2-2/investorhub/</loc>
		<lastmod>2023-11-27T00:03:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/?attachment_id=4326</loc>
		<lastmod>2023-12-19T07:52:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://adalta-elementor.cclayers.com/?attachment_id=4327</loc>
		<lastmod>2023-12-19T07:52:22+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->